Related Experiment Video
Updated: Aug 15, 2026

Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein
Published on: July 27, 2016
Raising an isolated low HDL-C level: why, how, and when?
1Center for Preventive Cardiology, Department of Medicine and Epidemiology, University of Maryland Medical Center, Baltimore 21201, USA. mmiller@heart.umaryland.edu
Insights
Treating low high-density lipoprotein cholesterol (HDL-C) requires assessing overall coronary heart disease (CHD) risk. Lifestyle changes and tailored drug therapies can modestly increase HDL-C, potentially reducing CHD event risk.
Area of Science:
- Cardiology
- Metabolic Disorders
- Preventive Medicine
Background:
- Isolated low high-density lipoprotein cholesterol (HDL-C) presents a therapeutic challenge.
- Patient management necessitates a comprehensive assessment of coronary heart disease (CHD) risk.
Purpose of the Study:
- To outline strategies for managing patients with low HDL-C.
- To emphasize the importance of personalized treatment approaches.
Main Methods:
- Review of current lifestyle interventions for HDL-C improvement.
- Evaluation of available pharmacologic therapies targeting HDL-C.
- Risk stratification for coronary heart disease (CHD).
Main Results:
- No single therapy is currently optimal for raising HDL-C.
- Various interventions can achieve modest increases in HDL-C levels.
- These increases correlate with a reduced risk of CHD events.
Conclusions:
- Treatment decisions for low HDL-C should be individualized based on CHD risk.
- Tailored lifestyle and drug therapies are crucial.
- Modest HDL-C elevations can contribute to cardiovascular risk reduction.
Abstract:
Treating patients with isolated low high-density lipoprotein cholesterol (HDL-C) remains daunting. The decision to treat depends on the individual patient's overall risk for coronary heart disease (CHD). Strategies for raising HDL-C levels can include various lifestyle and drug therapies, which should be tailored to individual patients. While no current therapy is optimal, many can yield modest increases that translate into reduced risk for CHD events.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management

